Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Cooper S, Westley RL, Biscombe K, Dunlop A, Mitchell A, Oelfke U, Nill S, Manning G, Burnett S, Murray J, Wilkins A, Tunariu N, Price D, Adkins A, Pathmanathan A, Bucinskaite G, Hafeez S, Parker C, Ratnakumaran R, Verkooijen H, Alexander S, Herbert T, Hall E, Tree AC. Cooper S, et al. Among authors: tree ac. Int J Radiat Oncol Biol Phys. 2025 Nov 1;123(3):773-782. doi: 10.1016/j.ijrobp.2025.05.008. Epub 2025 May 20. Int J Radiat Oncol Biol Phys. 2025. PMID: 40403882 Free article. Clinical Trial.
Simulation-free radiotherapy on the MR-linac in prostate cancer.
Cooper S, Chick J, Casey F, Alexander S, Nill S, Oelfke U, Tree A, Dunlop A. Cooper S, et al. Among authors: tree a. Br J Radiol. 2025 Oct 1;98(1174):1591-1595. doi: 10.1093/bjr/tqaf163. Br J Radiol. 2025. PMID: 40700595 Free PMC article.
Apparent diffusion coefficient as a quantitative biomarker for prostate cancer treatment response on a 1.5 Tesla magnetic resonance-linear accelerator: Impact of image registration and acquisition type.
Nair PP, Chick J, Nuixe M, Lecoeur B, Xiao Y, Cooper S, Tree AC, van Houdt PJ, Oelfke U, Wetscherek A. Nair PP, et al. Among authors: tree ac. Phys Imaging Radiat Oncol. 2025 Oct 13;36:100851. doi: 10.1016/j.phro.2025.100851. eCollection 2025 Oct. Phys Imaging Radiat Oncol. 2025. PMID: 41146990 Free PMC article.
Primary endpoint analysis of the phase II DESTINATION-MRL trial for patients with intermediate-risk prostate cancer.
Dassen MG, Tree AC, Wiersema L, Neijndorff B, de Ruiter P, van der Linden J, Mitchell A, Dunlop A, Alexander S, Breitkreutz DY, Cooper S, Janssen T, Pos F, Vesprini D, van der Heide UA. Dassen MG, et al. Among authors: tree ac. Int J Radiat Oncol Biol Phys. 2025 Nov 26:S0360-3016(25)06502-2. doi: 10.1016/j.ijrobp.2025.11.028. Online ahead of print. Int J Radiat Oncol Biol Phys. 2025. PMID: 41314554 Free article.
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Zamboglou C, Doncker W, Christoforou AT, Arcangeli S, Berlin A, Blanchard P, Bauman G, Campi R, Castro E, Choudhury A, Pra AD, Draulans C, Desai N, Ferentinos K, Francolini G, Gillessen S, Grosu AL, Rivas JG, Hoelscher T, Hruby G, Jereczek-Fossa BA, Kamran S, Kasivisvanathan V, Kishan AU, Kounnis V, Loblaw A, Martin J, Mastroleo F, Merseburger AS, Miszczyk M, Mohamad O, Ost P, Papatsoris A, Peeken JC, Sanguedolce F, Sargos P, Schmidt-Hegemann N, Seibert TM, Shelan M, Siva S, Soeterik TFW, Spratt DE, Stenzl A, Strouthos I, Sutera P, Supiot S, Tilki D, Tran PT, Tree AC, Tward J, Ürün Y, Vapiwala N, Waddle MR, Wegener E, Zilli T, Murthy V, Thieme AH, Spohn S. Zamboglou C, et al. Among authors: tree ac. Radiother Oncol. 2025 Sep;210:111039. doi: 10.1016/j.radonc.2025.111039. Epub 2025 Jul 9. Radiother Oncol. 2025. PMID: 40645505
197 results